BRCA2 functions: from DNA repair to replication fork stabilization
- PMID: 27530658
- DOI: 10.1530/ERC-16-0297
BRCA2 functions: from DNA repair to replication fork stabilization
Abstract
Maintaining genomic integrity is essential to preserve normal cellular physiology and to prevent the emergence of several human pathologies including cancer. The breast cancer susceptibility gene 2 (BRCA2, also known as the Fanconi anemia (FA) complementation group D1 (FANCD1)) is a potent tumor suppressor that has been extensively studied in DNA double-stranded break (DSB) repair by homologous recombination (HR). However, BRCA2 participates in numerous other processes central to maintaining genome stability, including DNA replication, telomere homeostasis and cell cycle progression. Consequently, inherited mutations in BRCA2 are associated with an increased risk of breast, ovarian and pancreatic cancers. Furthermore, bi-allelic mutations in BRCA2 are linked to FA, a rare chromosome instability syndrome characterized by aplastic anemia in children as well as susceptibility to leukemia and cancer. Here, we discuss the recent developments underlying the functions of BRCA2 in the maintenance of genomic integrity. The current model places BRCA2 as a central regulator of genome stability by repairing DSBs and limiting replication stress. These findings have direct implications for the development of novel anticancer therapeutic approaches.
Keywords: BRCA2; DNA double-stranded break repair; DNA replication; Fanconi anemia; cancer therapy; genomic stability; homologous recombination; replication stress.
© 2016 Society for Endocrinology.
Similar articles
-
Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.Mutat Res. 2014 Aug-Sep;766-767:66-72. doi: 10.1016/j.mrfmmm.2014.06.003. Epub 2014 Jun 22. Mutat Res. 2014. PMID: 25847274
-
Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.Mutat Res. 2014 Aug-Sep;766-767:66-72. doi: 10.1016/j.mrfmmm.2014.06.003. Epub 2014 Jun 22. Mutat Res. 2014. PMID: 25773776 Free PMC article.
-
Guardians of the Genome: BRCA2 and Its Partners.Genes (Basel). 2021 Aug 10;12(8):1229. doi: 10.3390/genes12081229. Genes (Basel). 2021. PMID: 34440403 Free PMC article. Review.
-
Therapeutic exploitation of tumor cell defects in homologous recombination.Anticancer Agents Med Chem. 2008 May;8(4):448-60. doi: 10.2174/187152008784220267. Anticancer Agents Med Chem. 2008. PMID: 18473729 Review.
-
Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.Mutat Res. 2006 Oct 10;601(1-2):191-201. doi: 10.1016/j.mrfmmm.2006.07.003. Epub 2006 Aug 21. Mutat Res. 2006. PMID: 16920162
Cited by
-
Mitochondrial DNA: cellular genotoxic stress sentinel.Trends Biochem Sci. 2021 Oct;46(10):812-821. doi: 10.1016/j.tibs.2021.05.004. Epub 2021 Jun 1. Trends Biochem Sci. 2021. PMID: 34088564 Free PMC article. Review.
-
Single-Cell Analysis of Histone Acetylation Dynamics at Replication Forks Using PLA and SIRF.Methods Mol Biol. 2023;2589:345-360. doi: 10.1007/978-1-0716-2788-4_23. Methods Mol Biol. 2023. PMID: 36255636
-
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. eCollection 2019. J Cancer. 2019. PMID: 31205572 Free PMC article. Review.
-
Rice OsBRCA2 Is Required for DNA Double-Strand Break Repair in Meiotic Cells.Front Plant Sci. 2020 Nov 16;11:600820. doi: 10.3389/fpls.2020.600820. eCollection 2020. Front Plant Sci. 2020. PMID: 33304374 Free PMC article.
-
FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers.Cancers (Basel). 2021 Apr 14;13(8):1866. doi: 10.3390/cancers13081866. Cancers (Basel). 2021. PMID: 33919707 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous